News
A court battle between two of the nation’s largest biotechs is testing the legal limits of how far drugmakers can go in using ...
Pharmalittle: We’re reading about Regeneron’s patent maneuvers, FDA rejection letters, and lots more
A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...
Several pharma companies lose out in a ruling that prevents them making generic oxycodone over fears of misuse. In a controversial decision that hands a victory to Purdue Pharma, the US Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback